Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

Equities

301130

CNE1000058C4

Pharmaceuticals

End-of-day quote Shenzhen S.E. 03:30:00 07/05/2024 am IST 5-day change 1st Jan Change
26.25 CNY +1.78% Intraday chart for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd +4.00% -5.85%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024. CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on February 23, 2024. CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Executive Appointments CI
Xidian Pharmaceutical’s Depression Drug Added to Procurement Program MT
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for 2022, Payable on June 12, 2023 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Cash Dividend for the Year 2022 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-FEB-2023. CI
Xidian Pharma's Shareholder and Party Acting in Concert Plan to Unload Stake CI
Certain A Shares of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 24-JAN-2023. CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 30 June 2022 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Approves Cash Dividend for the Year 2021 CI
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Proposes Final Dividend for 2021 CI
Chart Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
More charts
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of chemical active pharmaceutical ingredients (APIs) and preparations. The Company's products cover the fields of anti anemia drugs, drugs for the treatment of mental disorders and the production of APIs, such as compound ferrous sulfate folic acid tablets, risperidone orally disintegrating tablets, escitalopram oxalate tablets, daphnetin capsules, sodium ferulate and ferrous fumarate.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 301130 Stock
  4. News Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
  5. Xidian Pharmaceutical’s Depression Drug Added to Procurement Program
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW